The Road to Quality Improvement in HER2-Positive Breast Cancer

Program Goals

What Is Quality Improvement?

QI and HER2-positive Breast Cancer

Defining HER2-positive Status

Importance of Accuracy

Metastatic Disease and Testing

Treatment Guidelines for Metastatic HER2 Disease in the First-line Setting

Results of the CLEOPATRA Trial

Recommendations for Duration of Therapy

Treatment for Patients Who Are HER2-positive and HR-positive

Recommendations for Progression

Results of the EMILIA Trial

Related Issues

Brain Metastases: ASCO Guidelines

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)